Literature DB >> 12608928

Hormone replacement therapy: current controversies.

Sonia Davison1, Susan R Davis.   

Abstract

Postmenopausal hormonal therapy is used to manage the climacteric symptoms that impair the quality of life of a substantial number of women. The difficulty is achieving the desired effects with minimal side-effects and no adverse health risks. Fundamental to this is understanding the physiology of oestrogen in women and the metabolism of the therapeutic compounds. Although the effects of oral oestrogen therapy have been studied extensively, there is insufficient evidence to assess adequately the independent effects of progestin use, other oestrogen compounds, differing doses and duration of treatment. We have reviewed some basic concepts of oestrogen physiology and how these relate to exogenous oestrogen administration, the risks of greatest concern, and the role of androgens and newer treatment alternatives.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12608928     DOI: 10.1046/j.1365-2265.2003.01774.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  17 in total

1.  The beneficial effect of Radix Dipsaci total saponins on bone metabolism in vitro and in vivo and the possible mechanisms of action.

Authors:  Y B Niu; Y H Li; X H Kong; R Zhang; Y Sun; Q Li; C Li; L Liu; J Wang; Q B Mei
Journal:  Osteoporos Int       Date:  2012-04-26       Impact factor: 4.507

Review 2.  Pharmacological therapy for female sexual dysfunction: has progress been made?

Authors:  Susan R Davis; Esme A Nijland
Journal:  Drugs       Date:  2008       Impact factor: 9.546

3.  32k Da protein improve ovariectomy-induced bone loss in rats.

Authors:  Yingtang Zhou; Shenhua Jiang; Jing Chen; Tao Wang; DengZhao Jiang; Hui Chen; Huan Yu
Journal:  Prion       Date:  2013-08-07       Impact factor: 3.931

4.  Therapeutic effects of radix dipsaci, pyrola herb, and Cynomorium songaricum on bone metabolism of ovariectomized rats.

Authors:  Meijie Liu; Gary Guishan Xiao; Peijing Rong; Zhiguo Zhang; Jiazi Dong; Hongyan Zhao; Honghong Li; Yan Li; Jinghua Pan; Hong Liu; Wenlai Wang; Qinglin Zha; Dahong Ju
Journal:  BMC Complement Altern Med       Date:  2012-05-28       Impact factor: 3.659

5.  Low salivary testosterone levels in patients with breast cancer.

Authors:  Constantine Dimitrakakis; David Zava; Spyros Marinopoulos; Alexandra Tsigginou; Aris Antsaklis; Rebecca Glaser
Journal:  BMC Cancer       Date:  2010-10-11       Impact factor: 4.430

6.  The osteoprotective effect of Herba epimedii (HEP) extract in vivo and in vitro.

Authors:  Fang Xie; Chun-Fu Wu; Wan-Ping Lai; Xu-Juan Yang; Pik-Yuan Cheung; Xin-Sheng Yao; Ping-Chung Leung; Man-Sau Wong
Journal:  Evid Based Complement Alternat Med       Date:  2005-07-26       Impact factor: 2.629

7.  The effects of Cosmos caudatus (ulam raja) on dynamic and cellular bone histomorphometry in ovariectomized rats.

Authors:  Norazlina Mohamed; Zulaikha Sahhugi; Elvy Suhana Mohd Ramli; Norliza Muhammad
Journal:  BMC Res Notes       Date:  2013-06-24

8.  Evidence-based assessment of antiosteoporotic activity of petroleum-ether extract of Cissus quadrangularis Linn. on ovariectomy-induced osteoporosis.

Authors:  Bhagath K Potu; Muddanna S Rao; Gopalan K Nampurath; Mallikarjuna R Chamallamudi; Keerthana Prasad; Soubhagya R Nayak; Praveen K Dharmavarapu; Vivekananda Kedage; Kumar M R Bhat
Journal:  Ups J Med Sci       Date:  2009       Impact factor: 2.384

9.  Lactobacillus fermentation enhances the inhibitory effect of Hwangryun-haedok-tang in an ovariectomy-induced bone loss.

Authors:  Ki-Shuk Shim; Taesoo Kim; Hyunil Ha; Kwang Jin Lee; Chang-Won Cho; Han Sung Kim; Dong-Hyun Seo; Jin Yeul Ma
Journal:  BMC Complement Altern Med       Date:  2013-05-16       Impact factor: 3.659

10.  Antiosteoporotic Effects of Huangqi Sanxian Decoction in Cultured Rat Osteoblasts by Proteomic Characterization of the Target and Mechanism.

Authors:  Chong-Chong Guo; Li-Hua Zheng; Jian-Ying Fu; Jian-Hong Zhu; Yan-Xing Zhou; Tao Zeng; Zhi-Kun Zhou
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-18       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.